The global nutritional supplements market size was USD 360.59 billion in 2023, calculated at USD 385.83 billion in 2024 and is expected to reach around USD 758.99 billion by 2034, expanding at a CAGR of 7% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nutritional Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nutritional Supplements Market, by Form Type, 2024-2034
8.1.1. Powder
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Tablets
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Capsules
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Liquid
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Soft gels
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Nutritional Supplements Market, by Product, 2024-2034
9.1.1. Sports Nutrition
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Dietary Supplements
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Fat Burner
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Functional Food
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Nutritional Supplements Market, by Age Group, 2024-2034
10.1.1. Kids
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adults
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Geriatric
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. Nutritional Supplements Market, by Distribution Channel, 2024-2034
11.1.1. Supermarkets/Hypermarkets
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Specialty Stores
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Pharmacies
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. E-commerce
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Form (2021-2034)
12.1.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Form (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Form (2021-2034)
12.2.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Form (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Form (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Form (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Form (2021-2034)
12.3.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Form (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Form (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Form (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Form (2021-2034)
12.4.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Form (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Form (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Form (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Form (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Form (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Age Group (2021-2034)
12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2034)
13.1. Abbott Nutrition
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Amway
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Nestle
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Glanbia Plc
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Herbalife International of America
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Archer Daniels Midland
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GlaxoSmithKline
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Nature’s Bounty Co.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Arkopharma Laboratories Pharmaceutiques
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. DuPont
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. American Health, Inc.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Pfizer, Inc.
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. Stepan Company
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client